There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Sulfonylurea drugs have been the only oral therapy available for patients with non-insulin-dependent
diabetes mellitus (NIDDM) in the United States. Recently, however, metformin has been
approved for the treatment of NIDDM.